A prevalence of 0.53% for Radiation Optic Neuropathy in NFA has been reported76. The incidence will decline with modern radiation therapy equipment and current recommended radiation therapy doses. An effective treatment for RON is not available76.
Permanent radiation induced damage of the cranial nerves III, IV, V and VI has not been reported in series with modern radiation therapy equipment and currently recommended radiation therapy doses.